Stock A011000 GENEONE LIFE SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2,460 KRW +1.03% Intraday chart for GeneOne Life Science, Inc. +1.03% -13.38%
Mar. 28 GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding CI
Mar. 27 GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 91,139 52,422 961,062 1,250,928 553,651 222,271
Enterprise Value (EV) 1 81,097 49,432 888,309 1,161,924 527,714 229,442
P/E ratio -7.66 x -6.77 x -54.3 x -75.3 x -14.5 x -2.84 x
Yield - - - - - -
Capitalization / Revenue 2.66 x 1.27 x 23.2 x 32.3 x 11.4 x 5.53 x
EV / Revenue 2.36 x 1.2 x 21.4 x 30 x 10.8 x 5.71 x
EV / EBITDA -6.07 x -10.2 x -61.2 x -50.6 x -15.2 x -6.45 x
EV / FCF -5.67 x -8.83 x -63.9 x -11.4 x -7.16 x -10.2 x
FCF Yield -17.6% -11.3% -1.56% -8.78% -14% -9.84%
Price to Book 3.1 x 2.18 x 9.76 x 6.09 x 3.05 x 1.99 x
Nbr of stocks (in thousands) 31,500 32,628 66,895 77,218 77,542 78,264
Reference price 2 2,893 1,607 14,367 16,200 7,140 2,840
Announcement Date 3/11/19 3/11/20 3/16/21 3/16/22 3/22/23 3/27/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 34,293 41,241 41,503 38,700 48,718 40,203
EBITDA 1 -13,368 -4,846 -14,508 -22,979 -34,776 -35,592
EBIT 1 -14,662 -8,266 -18,529 -27,609 -40,199 -48,368
Operating Margin -42.76% -20.04% -44.65% -71.34% -82.51% -120.31%
Earnings before Tax (EBT) 1 -11,735 -7,145 -18,226 -15,616 -38,054 -77,655
Net income 1 -11,898 -7,619 -18,648 -15,951 -38,150 -77,768
Net margin -34.69% -18.47% -44.93% -41.22% -78.31% -193.44%
EPS 2 -377.7 -237.3 -264.7 -215.0 -492.3 -1,000
Free Cash Flow 1 -14,303 -5,597 -13,891 -102,024 -73,691 -22,581
FCF margin -41.71% -13.57% -33.47% -263.63% -151.26% -56.17%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/11/19 3/11/20 3/16/21 3/16/22 3/22/23 3/27/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 7,171
Net Cash position 1 10,042 2,990 72,752 89,004 25,937 -
Leverage (Debt/EBITDA) - - - - - -0.2015 x
Free Cash Flow 1 -14,303 -5,597 -13,891 -102,024 -73,691 -22,581
ROE (net income / shareholders' equity) -36.1% -28.5% -30.4% -10.5% -19.7% -53.1%
ROA (Net income/ Total Assets) -19.3% -10.3% -12.3% -8.94% -10.6% -16.2%
Assets 1 61,626 74,061 151,145 178,442 359,662 480,905
Book Value Per Share 2 934.0 737.0 1,473 2,659 2,340 1,425
Cash Flow per Share 2 266.0 519.0 933.0 289.0 171.0 116.0
Capex 1 3,545 2,837 16,153 82,442 45,306 5,601
Capex / Sales 10.34% 6.88% 38.92% 213.03% 93% 13.93%
Announcement Date 3/11/19 3/11/20 3/16/21 3/16/22 3/22/23 3/27/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GENEONE LIFE SCIENCE, INC. Stock GeneOne Life Science, Inc.
-13.38% 142M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.67% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.55% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.66% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.96% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.57% 11.95B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+16.03% 11.32B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.80% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A011000 Stock
  4. Financials GeneOne Life Science, Inc.